Stone X Group Inc. Renalytix PLC Transaction History

Stone X Group Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$2.0 - $2.92 $26,686 - $38,961	13,343 New	13,343 $39,000
Q4 2022 Feb 10, 2023	BUY	$1.06 - $2.21 $51,999 - $108,413	49,056 New	49,056 $92,000
Q4 2021 Feb 10, 2022	SELL	$13.43 - $27.4 $257,359 - $525,066	-19,163 Closed	0 $0
Q3 2021 Oct 20, 2021	BUY	$17.91 - $34.78 $343,209 - $666,489	19,163 New	19,163 $384,000

3.91M

13.7K

Ticker RNLX
Exchange OTC
Sector Healthcare
Industry Health Information Services
Shares Outstandng 37,445,900
Market Cap $5.62M
Description
Renalytix Plc develops artificial intelligence-enabled in vitro diagnostic solutions for kidney diseases. The company offers KidneyIntelX, a diagnostic platform that employs an artificial intelligence-enabled algorithm that combines various data inputs, including validated blood-based biomarkers, inherited genetics and personalized patient data ...

Get notified when there are updates to the investment portfolio of Stone X Group Inc., based on Form 13F filings with the SEC.

Stay updated on Stone X Group Inc. with notifications on news.